GP404141 + Nplate

Phase 3Active
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Effect

Conditions

Drug Effect, Safety Issues, Immunogenicity

Trial Timeline

Apr 4, 2023 → Mar 31, 2028

About GP404141 + Nplate

GP404141 + Nplate is a phase 3 stage product being developed by GEROPHARM for Drug Effect. The current trial status is active. This product is registered under clinical trial identifier NCT06497036. Target conditions include Drug Effect, Safety Issues, Immunogenicity.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT06497036Phase 3Active